The association of polyserine with tau aggregates provides a molecular explanation for the mislocalization of SRRM2 to pathogenic tau inclusions in postmortem samples from AD, CBD, and FTLD patients (14, 17). This evidence concerns the gene SRRM2 and Alzheimer disease.